Abruptly stopping these antihistamines after long-term use without tapering can lead to severe itching, the FDA said.

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

Panelists discuss how ruxolitinib provides comprehensive benefits for polycythemia vera patients beyond count control, highlighting its remarkable ability to rapidly alleviate severe pruritus (often ...

The FDA has identified over 200 global cases of severe itching, or pruritus, occurring in patients who stopped long-term use ...